Wockhardt Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹965.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.67 per cent from ₹888.00 crore. This corresponds to a year-on-year *(YoY) growth of 29.88 per cent.
Operating Profit
Operating Profit stands at ₹225.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.73 per cent from ₹167.00 crore. This corresponds to a year-on-year *(YoY) growth of 251.56 per cent.
PBDT
PBDT stands at ₹242.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 83.33 per cent from ₹132.00 crore. This corresponds to a year-on-year *(YoY) growth of 680.65 per cent.
Profit Before Tax
Profit Before Tax stands at ₹189.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 182.09 per cent from ₹67.00 crore. This corresponds to a year-on-year *(YoY) growth of 959.09 per cent.
Net Profit
Net Profit stands at ₹164.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 168.85 per cent from ₹61.00 crore. This represents a 464.44 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Wockhardt Ltd News
Wockhardt Ltd Earnings
- YOY
- QOQ
Wockhardt Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Wockhardt Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Wockhardt Ltd Financial Reports
Wockhardt Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Wockhardt | 1.98% | 8.53% | 22.62% | 32.65% | 40.87% | 29.74% |
| Ajanta Pharma | -1.20% | -3.08% | 10.75% | 2.91% | 19.37% | 17.93% |
| J B Chemicals & | -0.34% | 0.45% | 7.02% | 5.39% | 23.51% | 31.29% |
| Emcure Pharma | -0.15% | -2.82% | 5.75% | 17.69% | 20.26% | 26.40% |
| Acutaas Chemical | -0.81% | 0.07% | 21.60% | 36.96% | 63.37% | 154.26% |
| Sai Life | -1.68% | -1.45% | 6.99% | 12.59% | 26.70% | 53.78% |
| Piramal Pharma | -1.57% | -0.03% | 7.03% | 14.97% | -6.14% | -13.31% |
Company Info
Company Information
Executive Chairman : H F Khorakiwala
Managing Director : Murtaza H Khorakiwala
Executive Director : Huzaifa H Khorakiwala
Independent Director : Vinesh Kumar Jairath
Non-Executive & Non-Independent Director : Zahabiya Khorakiwala
Independent Director : Akhilesh Gupta
Independent Director : Amelia Fernandes
Company Sec. & Compli. Officer : Rashmi Mamtura
Independent Director : Ahmad Javed
Additional Director : Om Prakash Bhatt